About us
Our Team
Our Board of Directors
Our Scientific Advisory Board
Our Collaborations
Technology
Manufacturing
pipeline
Neurodegenerative Diseases
Ocular Diseases
News
Press Releases
Careers
Contact
About us
Our Team
Our Board of Directors
Our Scientific Advisory Board
Our Collaborations
Technology
Manufacturing
pipeline
Neurodegenerative Diseases
Ocular Diseases
News
Press Releases
Careers
Contact
Category
Press Releases
20
Sep
Coave Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
20 September 2022
coavetx
Events
,
Press Releases
Read More
12
Sep
Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders
12 September 2022
coavetx
Press Releases
Read More
06
Sep
Coave Therapeutics Strengthens Leadership Team with the Appointments of Catherine Mathis as Vice President Regulatory Affairs and Julien Berger as Head of Legal Affairs
6 September 2022
coavetx
Press Releases
Read More
29
Jun
Coave Therapeutics Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Next-generation Gene Therapies Targeting CNS Diseases
29 June 2022
coavetx
Press Releases
Read More
09
Jun
Coave Therapeutics and ABL enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy
9 June 2022
coavetx
Press Releases
Read More
03
May
Coave Therapeutics to Present Data on its Chemically Engineered AAV Vectors for Gene Therapy in CNS Disease at ASCGT
3 May 2022
coavetx
Press Releases
Read More
27
Apr
Coave Therapeutics will be presenting an abstract at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held in Denver, Colorado 1-4 May 2022. The meeting will also be available for virtual attendees 11-12 May.
27 April 2022
coavetx
Press Releases
Read More
13
Apr
Coave Therapeutics to Present at Cell & Gene Meeting on the Mediterranean
13 April 2022
coavetx
Press Releases
Read More
15
Nov
Coave Therapeutics Strengthens Leadership Team with the Appointments of Thomas Blaettler MD as Chief Medical Officer and Patricia Françon PhD as Chief Operating Officer
15 November 2021
coavetx
Press Releases
Read More
12
Oct
Coave Therapeutics appoints Olivier Danos and Frederic Chereau as non-executive directors to its Board
12 October 2021
coavetx
Press Releases
Read More
1
2
Home
Press Releases
Events
WordPress Cookie Plugin by Real Cookie Banner